Metal complexes with superoxide dismutase-like activity as candidates for anti-prion drug.
Tomoko Fukuuchi, Katsumi Doh-Ura, Shin'ichi Yoshihara, Shigeru Ohta
Index: Bioorg. Med. Chem. Lett. 16 , 5982-7, (2006)
Full Text: HTML
Abstract
Various compounds were evaluated for ability to inhibit the formation of the abnormal protease-resistant form of prion protein (PrP-res) in two cell lines infected with different prion strains. Examination of the structure-activity relationships indicated that compounds with copper-selective chelating ability and whose copper complexes have high SOD-like activity are candidates for anti-prion drug.
Related Compounds
Related Articles:
2014-12-01
[J. Med. Microbiol. 63(Pt 12) , 1663-9, (2014)]
2014-12-01
[Anticancer Res. 34(12) , 7077-90, (2014)]
An analytical quality by design (aQbD) approach for a L-asparaginase activity method.
2016-01-05
[J. Pharm. Biomed. Anal. 117 , 232-9, (2015)]
Identifying chelators for metalloprotein inhibitors using a fragment-based approach.
2011-01-27
[J. Med. Chem. 54 , 591-602, (2011)]
2015-03-06
[Eur. J. Med. Chem. 92 , 302-13, (2015)]